Profile
Dimension Capital is a venture capital firm based in New York City, founded by Zavain Dar and Adam Goulburn. The firm is known for its multistage, research-oriented approach, partnering with companies at the forefront of science and computing. The team includes Simon Barnett, Bauer LeSavage, and Frank Gao, who together bring a diverse range of expertise from life sciences research to computational science, exemplifying the firm’s unique focus on the intersection of technology, machine learning, and life sciences.
Dimension Capital invests across a wide range of sectors including AI, Machine Learning (ML), Life Sciences, and Biotech. They support stages from seed to late-stage investments, with check sizes that typically fall between $10 to $50 million. The firm is currently managing its third fund, Dimension Capital III, with a target of $750 million. Their strategic approach involves a deep research focus to back companies that operate at the technological cutting edge globally.
Notable investments include companies like ImmuneBridge - a cell therapy platform, and several others at similar intersections of technology and life sciences. Their investment philosophy centers on leveraging multidisciplinary innovations to foster breakthroughs that can redefine industries and improve lives globally.
Industry
Dimension Capital Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Dimension Capital III, L.P.
|
Venture Capital (VC)
|
AI
Technology
|
Pre-seed
Seed
Series A
Series B
Late Stage (Series C+)
|
North America
|
$10-50 m
|
$750 M
|
June 2026
|
|
Dimension III
|
Venture Capital (VC)
|
Biotechnology
Hardware
Medical Devices
Software
AI
Life Sciences
HealthTech
|
Seed
Series A
Series B
Late Stage (Series C+)
|
North America
|
$10-50 m
|
$800 M
|
July 2026
|
|
Dimension Capital II
|
Venture Capital (VC)
|
New materials
Machine Learning (ML)
HealthTech
Infrastructure
Life Sciences
Technology
MedTech
AI
Software
Pharmaceuticals
Medical Devices
Healthcare Services
Hardware
Biotechnology
|
Pre-seed
Seed
Series A
Series B
Late Stage (Series C+)
|
Asia
North America
|
$10-50 m
|
$500 M
|
January 2024
|
Contacts
Instant access on the web. Plans from $129/month — see pricing.